Abstract
Tardive dyskinesia (TD), a movement disorder produced by long-term treatment with a classical antipsychotic drug, is generally considered to be a disorder of dopamine (DA) systems, since classical antipsychotics are potent DA D2 receptor blockers. Also, acute DA D1 agonist treatment of rats is known to produce vacuous chewing movements (VCMs), a behavioral feature resembling the oral dyskinesia that is so prominent in most instances of TD. In this paper we outline a series of studies in a new animal model of TD in which DA D1 receptor supersensitivity was produced by neonatal 6-hydroxydopamine (6-OHDA) -induced destruction of nigrostriatal DA fibers. In rats so-lesioned 5-HT receptor supersensitivity is additionally produced, and in fact 5-HT receptor antagonists attenuate enhanced DA D16-lesioned rats treated with haloperidol for one year, there is a 2-fold increase in numbers of VCMs (versus intact rats treated with haloperidol); and this high frequency of VCMs persists for more than 6 months after discontinuing haloperidol treatment. During this stage, 5-HT2 receptor antagonists, but not DA D1 receptor antagonists, attenuate the incidence of VCMs. This series of findings implicates the 5-HT neuronal phenotype in TD, and promotes 5-HT2 receptor antagonists, more specifically 5-HT2C receptor antagonists, as a rational treatment approach for TD in humans.
Similar content being viewed by others
References
Arnt J, J Hyttel and J Perregard (1987) Dopamine D-1 receptor agonists combined with the selective D-2 agonist, quinpirole, facilitate the expression of oral stereotyped behaviour in rats.Eur. J. Pharmacol. 133, 137–145.
Berger TW, S Kaul, EM Stricker and MJ Zigmond (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats.Brain Res. 366, 354–358.
Breese GR, AA Baumeister, TJ McCown, SG Emerick, GD Frye, K Crotty and RA Mueller (1984) Behavioural differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.J. Pharmacol. Exp. Ther. 231, 343–354.
Breese GR, A Baumeister, TC Napier, GD Frye and RA Mueller (1985) Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.J. Pharmacol. Exp. Ther. 235, 287–295.
Breese GR, GE Duncan, TC Napier, SC Bondy, LC Iorio and RA Mueller (1987) 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1 and D2-dopamine agonists into the nucleus accumbens and striatum without changing dopamine antagonist binding.J. Pharmacol. Exp. Ther. 240, 167–176.
Brown RW, SK Thacker, MK Perna, KJ Smith, JJ Ward, TL Schaefer, MT Williams and RM Kostrzewa (2005) Chronic adulthood olanzapine treatment eliminates D2 receptor priming and cognitive deficits produced by neonatal quinpirole treatment.Soc. Neurosci. Abstr. #884.7.
Brus R, RM Kostrzewa, KW Perry and RW Fuller (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.J. Pharmacol. Exp. Ther. 268, 231–237.
Casey DE (1987) Tardive dyskinesia, In:Psychopharmacology: the Third Generation of Progress (Meltzer HY, Ed.) (Raven Press: New York), pp 1411–1419.
Criswell H, RA Mueller and GR Breese (1989) Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats.J. Neurosci. 9, 125–133.
Criswell H, RA Mueller and GR Breese (1990) Long-term D1-dopamine receptor sensitization in neonatal-6-OHDA-lesioned rats is blocked by an NMDA antagonist.Brain Res. 512, 284–290.
Dewar KM, J-J Soghomonian, JP Bruno, L Descarries and TA Reader (1990) Elevation of dopamine D2 but not D1 dopamine receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation.Brain Res. 536, 287–296.
Doucet G, L Descarries and S Garcia (1986) Quantification of the dopamine innervation in adult rat neostriatum.Neuroscience 19, 427–445.
Duncan GE, HE Criswell, TJ McCown, IA Paul, RA Mueller and GR Breese (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.J. Pharmacol. Exp. Ther. 243, 1027–1034.
El Mansari MF Radja, A Ferron, TA Reader, E Molina-Holgado and L Descarries (1994) Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation.Eur. J. Pharmacol. 261, 171–178.
Ellison GD and RE See (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia.Psychopharmacology (Berl.) 98, 564–566.
Fernandes Xavier FG, G Doucet, M Geffard and L Descarries (1994) Dopamine neoinnervation in the substantia nigra and hyperinnervation in the interpeduncular nucleus of adult rat following neonatal cerebroventricular administration of 6-hydroxydopamine.Neuroscience 59, 77–87.
Gong L and RM Kostrzewa (1992) Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats.Pharmacol. Biochem. Behav. 41, 621–623.
Gong L, RM Kostrzewa, RW Fuller and KW Perry (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.J. Pharmacol. Exp. Ther. 261, 1000–1007.
Gong L, RM Kostrzewa, R Brus, RW Fuller and KW Perry (1993a) Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats.Dev. Brain Res. 76, 59–65.
Gong L, RM Kostrzewa, KW Perry and RW Fuller (1993b) Dose-related effects of a neonatal 6-OHDA lesion on SKF-38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.Dev. Brain Res. 76, 233–238.
Gong L, RM Kostrzewa and C Li (1994) Neonatal 6-hydroxydopamine and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats.J. Neurochem. 63, 1282–1290.
Gunne LM, SE Bachus and K Gale (1988) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration.Psychopharmacology (Berl.) 77, 134–139.
Huang N-Y and RM Kostrzewa (1994) Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats.Eur. J. Pharmacol. 253, 163–166.
Huang N-Y, RM Kostrzewa, C Li, KW Perry and RW Fuller (1997) Increased spontaneous oral dyskinesias persist in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.J. Pharmacol. Exp. Ther. 280, 268–276.
Jeste DV and MP Caligiuri (1993) Tardive dyskinesia.Schizophr. Bull. 19, 303–315.
Koshikawa N, S Aoki, M Tomiyama, Y Maruyama and M Kobayashi (1987) Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.Eur. J. Pharmacol. 133, 119–125.
Kostrzewa RM (1995) Dopamine receptor supersensitivity.Neurosci. Biobehav. Rev. 19, 1–17.
Kostrzewa RM and L Gong (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA.Pharmacol. Biochem. Behav. 39, 677–682.
Kostrzewa RM and AHamdi (1991) Potentiation of spiperoneinduced oral activity in rats after neonatal 6-hydroxydopamine.Pharmacol. Biochem. Behav. 38, 215–218.
Kostrzewa RM, R Brus, KW Perry and RW Fuller (1993) Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.Dev. Brain. Res. 76, 87–93.
Kostrzewa RM, TA Reader and L Descarries (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.J. Neurochem. 70, 889–898.
Levin ED, RE See and D South (1989) Effects of dopamine D1 and D2 receptor antagonists on oral activity in rats.Pharmacol. Biochem. Behav. 34, 43–48.
Luthman J, B Botioli, T Tustsumi, A Verhofstad and G Jonsson (1987) Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat.Brain Res. Bull. 19, 269–274.
Molloy AG and JL Waddington (1988) Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rat.Br. J. Pharmacol. 95, 335–342.
Moy SS, A Fernandez, Y Qian, DL Rotella, RM Kostrzewa and GR Breese (2004) Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss.Pharmacol. Biochem. Behav. 78, 47–56.
Mrini A, J-P Soucy, F Lafaille, P Lemoine and L Descarries (1995) Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons.Brain Res. 669, 303–308.
Murray AM and JL Waddington (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.Eur. J. Pharmacol. 160, 377–387.
Plech A, R Brus, JH Kalbfleisch and RM Kostrzewa (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.Psychopharmacology (Berl.) 119, 466–473.
Radja F, M El Mansari, J-J Soghomonian, KM Dewar, A Ferron, TA Reader and L Descarries (1993 a) Changes in D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.Neuroscience 57, 635–648.
Radja F, L Descarries, KM Dewar and TA Reader (1993b) Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study.Brain Res. 606, 273–285.
Rosengarten H, JW Schweitzer and AJ Friedhoff (1983a) Induction of oral dyskinesias in naïve rats by D1 stimulation.Life Sci. 33, 2479–2482.
Rosengarten H, JW Schweitzer, J Egawa and AJ Friedhoff (1983b) Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.A dv. Exp. Med. Biol. 235, 159–169.
Rosengarten H, JW Schweitzer, J Egawa and AJ Friedhoff (1986) Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.Adv. Exp. Med. Biol. 235, 159–167.
Rosengarten H, GD Bartoszyk, D Quartermain and Y Lin (2006) The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 273–279. Epub 2005 Oct 17.
Rupniak NMJ, P Jenner and CD Marsden (1985) Pharmacological characterization of spontaneous or drug-associated purposeless chewing movements in rats.Psychopharmacology (Berlin) 85, 71–79.
Snyder AM, MJ Zigmond and RD Lund (1986) Sprouting of serotonergic afferents into striatum after dopamine depleting lesions in infant rats: a retrograde transport and immunocytochemical study.J. Comp. Neurol. 245, 274–281.
Stachowiak MK, JP Bruno, AM Snyder, EM Stricker and MJ Zigmond (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats.Brain Res. 291, 164–167.
Towle AC, HE Criswell, EH Maynard, JM Lauder, RH Joh and RA Mueller and GR Breese (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study.Pharmacol. Biochem. Behav. 34, 367–374.
Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia.Psychopharmacology (Berl.) 101, 431–447.
Waddington JL, AJ Cross, SJ Gamble and RC Bourne (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.Science 220, 530–532.
Waddington JL, AM Murray, E O’Callaghan and C Larkin (1989) Orofacial dyskinesia: D-1/D-2 dopamine receptors in rodents, and familial/obstetric correlates of tardive dyskinesia in schizophrenia, In:Neural Mechanisms in Disorders of Movement (AR Crossman and MA Sambrook, Eds.) (Libbey: London), pp 359–366.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kostrzewa, R.M., Huang, NY., Kostrzewa, J.P. et al. Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment. neurotox res 11, 41–50 (2007). https://doi.org/10.1007/BF03033481
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033481